Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.9 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |